Quality Systems

Articles

Malvern Instruments Opens New Applications Laboratory in Brazil; Roche To Invest in Diagnostics Production in Germany; and More.

Week of December 17, 2012: Malvern Instruments Opens New Applications Laboratory in Brazil; Roche To Invest in Diagnostics Production in Germany; and More

Jane Wan is a freelance writer based in Singapore.

Domestic companies are changing their business models in response to recent drug price cuts.

Report from South Korea

Sean Milmo is a freelance writer based in Essex, UK.

The government of Turkey is drawing up a program in coordination with the pharmaceutical industry to create ways to make the country a regional production center for pharmaceuticals serving Europe, Central Asia, and the Middle East.

Report from Turkey

Foreign firms struggle against stricter patent laws, but all is not lost.

Report from India

Brazil takes first steps towards gaining quality requirements for pharmaceutical excipients.

Report from Brazil September 2012

After a series of government reforms that are appealing to both domestic and foreign players, the Japanese pharmaceutical market is making a comeback.

Report from Japan

Q&A with Peter Smith, Strategic Compliance Consulting, PAREXEL International, and a former senior official with FDA, on change management best practices.

Regulation and Compliance Q&A: Change Management

New price-control policy has domestic and global firms waiting on the sidelines to launch products.

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The decision by the Indian patent authorities to issue a compulsory license for a generic version of a Bayer anticancer drug engenders debate.

Pharmaceutical Industry Faces Compulsory Licensing in India

China's drug-distribution network has been a mess for years, but government reforms and industry focus are unveiling new opportunities for market order and growth.

Regulatory/GMP Compliance, Emerging Markets